Heart failure affects a significant portion of the Australian population, with an estimated 325,000 patients grappling with this condition. Among these patients, those with refractory heart failure often find relief in continuous flow left ventricular assist devices (cfLVADs) as a bridge to transplantation. Globally, over 25,000 individuals have been supported with cfLVADs, with implantation rates surpassing 3,000 patients annually and continuing to rise. However, while these devices offer a lifeline, they come with their own set of challenges.
We acknowledge the Traditional Owners of this country, including the Gadigal people of the Eora nation – whose lands on which this Clinic is built, and recognise their continuing connection to land, waters, and culture. We pay our respects to their Elders’s past, present and emerging.